Patient Assistance Programme Evaluation for Cardiovascular Conditions
Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component of the PAP (e.g. brochures, website, videos, training kits, patient emails), the clarity of each component and their usefulness across the patient journey. They also wanted to identify any gaps or needs for improvement in the PAP.
Multiple Sclerosis new medical device research
Our client wanted to find out how best to develop an implantable delivery device with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a device would be accepted by HCPs and patients. We also needed to identify the perceived benefit to stakeholders and offer ideas on how to optimize the device offering through the look of the device, its design and additional features.
Shifting perceptions of the use of probiotics in IBS Management
Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amongst a range of healthcare professionals in emerging markets. They wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to their patients.
Understanding the patient journey and addiction treatment pathways
Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and the issues that this large proportion of their customers and potential HCP treaters were facing. Therefore, they were seeking further insights to gain a 360 degree understanding to better serve their customers needs.
Qualitative research with payers in low and middle income countries
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and middle income countries where patients self-pay for healthcare.
They also wanted to obtain a deep understanding of the groups of patients for whom self-pay is an issue and the sources of public funding that could potentially be leveraged. Our findings would complement market access considerations and point the way forward to a self-pay strategy that would maximise the potential for our client’s product.